Freedom Day Solutions’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-24,272
Closed -$1.87M 80
2018
Q3
$1.87M Sell
24,272
-1,931
-7% -$146K 1.48% 32
2018
Q2
$1.86M Buy
26,203
+118
+0.5% +$8.33K 1.51% 30
2018
Q1
$1.97M Sell
26,085
-848
-3% -$67.4K 1.72% 28
2017
Q4
$1.93M Buy
+26,933
New +$2.05M 1.63% 33

Other funds holding GILD

Freedom Day Solutions's GILD Position: Q4 2018 in Review

Freedom Day Solutions sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 24,272 shares — an estimated $1.87M sold.

Freedom Day Solutions first reported a position in GILD in Q4 2017 and held it in 4 quarters. The position peaked at $1.97M in Q1 2018. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Freedom Day Solutions reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Freedom Day Solutions sold 24,272 Gilead Sciences shares in Q4 2018, an estimated $1.87M.
  • Freedom Day Solutions first reported a position in Gilead Sciences in Q4 2017 and held it in 4 quarters.
  • Freedom Day Solutions's Gilead Sciences position peaked at $1.97M in Q1 2018.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Freedom Day Solutions's 13F filing for Q4 2018, filed 28 Jan 2019.